We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Ryan Specialty Shares Gain 9% in 3 Months: What's Driving the Rally?
Read MoreHide Full Article
Key Takeaways
Ryan Specialty gained 9% in three months, beating the industry's 2.5% gain and the S&P 500's 5.2% rise.
RYAN's Q2 adjusted EPS rose 12.1% to 74 cents, topping the consensus estimate by 21.3%.
Ryan Specialty repurchased $260 million of shares and improved its 2026 adjusted EBITDAC margin outlook.
Shares of Ryan Specialty Holdings, Inc. (RYAN - Free Report) have climbed 9% over the past three months, outpacing the industry’s 2.5% growth and the S&P 500’s 5.2% rise. The advance reflects a mix of index-related buying, better-than-expected second-quarter results, an improved margin outlook and steady capital returns.
3-Month Price Performance – RYAN, Industry and S&P 500
Image Source: Zacks Investment Research
Let’s delve deeper.
Russell index reconstitution gave the stock an early lift after Ryan Specialty was added to the Russell 1000 Value and Russell Midcap Value benchmarks. Such changes often attract buying from passive and benchmark-tracking funds, helping support trading activity around the rebalancing period.
Fundamentals then added to the momentum. Ryan Specialty reported second-quarter adjusted earnings of 74 cents per share, up 12.1% year over year and 21.3% above the Zacks Consensus Estimate of 61 cents. Organic revenue growth was 6.7%, supported by new business wins, strong retention, broader relationships with existing clients and continued movement of risks into specialty and excess-and-surplus markets.
Management also kept its mid-single-digit organic growth outlook while improving its 2026 adjusted EBITDAC margin guidance. The updated view points to better cost control and operating leverage than previously expected.
Capital returns provided another layer of support. Ryan Specialty repurchased 8.1 million shares for $260 million in the second quarter and paid $24.5 million in dividends. At June-end, $300 million remained available under its buyback authorization.
The company is also expanding its underwriting capabilities. Recent moves include a Lloyd’s consortium arrangement, the formation of Ryan Specialty Renewables and the launch of Tera Underwriters. Tera offers more than $1 billion of accessible capacity for industrial-scale computing hardware, including AI and high-performance computing data centers.
Earnings Estimates Are Moving Higher for RYAN
The Zacks Consensus Estimate for Ryan Specialty’s 2026 earnings is currently pegged at $2.18 per share, which indicates 11.2% year-over-year growth. It witnessed nine upward revisions and no cuts over the past 60 days. The consensus mark for 2027 EPS indicates a further 12.5% year-over-year growth. It beat earnings estimates in two of the past four quarters, met once and missed on the other occasion, with an average surprise of 5.2%.
Meanwhile, the Zacks Consensus Estimate for RYAN’s 2026 and 2027 revenues is pegged at $3.30 billion and $3.54 billion, signaling 8.1% and 7.3% increases, respectively.
Zacks Rank & Key Picks
Ryan Specialty currently has a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Assurant’s current-year earnings is pegged at $22.28 per share, which indicates 12.7% year-over-year growth. It has witnessed five upward estimate revisions against none in the opposite direction in the past 60 days. AIZ beat earnings estimates in each of the last four quarters, with an average surprise of 17.7%.
The consensus mark for CNO Financial’s current-year earnings is pegged at $4.74 per share, which indicates 16.2% year-over-year growth. It has witnessed two upward estimate revisions against none in the opposite direction in the past 60 days. CNO beat earnings estimates in each of the last four quarters, with an average surprise of 23.2%.
The consensus estimate for Equitable Holdings’ current-year earnings is pegged at $7.18 per share, which signals a 15.6% year-over-year increase. It has witnessed four upward estimate revisions against none in the opposite direction in the past 60 days. EQH beat earnings estimates in three of the last four quarters and missed once.
View the Zacks #1 Rank List
Image: Bigstock
Ryan Specialty Shares Gain 9% in 3 Months: What's Driving the Rally?
Key Takeaways
Shares of Ryan Specialty Holdings, Inc. (RYAN - Free Report) have climbed 9% over the past three months, outpacing the industry’s 2.5% growth and the S&P 500’s 5.2% rise. The advance reflects a mix of index-related buying, better-than-expected second-quarter results, an improved margin outlook and steady capital returns.
3-Month Price Performance – RYAN, Industry and S&P 500
Let’s delve deeper.
Russell index reconstitution gave the stock an early lift after Ryan Specialty was added to the Russell 1000 Value and Russell Midcap Value benchmarks. Such changes often attract buying from passive and benchmark-tracking funds, helping support trading activity around the rebalancing period.
Fundamentals then added to the momentum. Ryan Specialty reported second-quarter adjusted earnings of 74 cents per share, up 12.1% year over year and 21.3% above the Zacks Consensus Estimate of 61 cents. Organic revenue growth was 6.7%, supported by new business wins, strong retention, broader relationships with existing clients and continued movement of risks into specialty and excess-and-surplus markets.
Management also kept its mid-single-digit organic growth outlook while improving its 2026 adjusted EBITDAC margin guidance. The updated view points to better cost control and operating leverage than previously expected.
Capital returns provided another layer of support. Ryan Specialty repurchased 8.1 million shares for $260 million in the second quarter and paid $24.5 million in dividends. At June-end, $300 million remained available under its buyback authorization.
The company is also expanding its underwriting capabilities. Recent moves include a Lloyd’s consortium arrangement, the formation of Ryan Specialty Renewables and the launch of Tera Underwriters. Tera offers more than $1 billion of accessible capacity for industrial-scale computing hardware, including AI and high-performance computing data centers.
Earnings Estimates Are Moving Higher for RYAN
The Zacks Consensus Estimate for Ryan Specialty’s 2026 earnings is currently pegged at $2.18 per share, which indicates 11.2% year-over-year growth. It witnessed nine upward revisions and no cuts over the past 60 days. The consensus mark for 2027 EPS indicates a further 12.5% year-over-year growth. It beat earnings estimates in two of the past four quarters, met once and missed on the other occasion, with an average surprise of 5.2%.
Meanwhile, the Zacks Consensus Estimate for RYAN’s 2026 and 2027 revenues is pegged at $3.30 billion and $3.54 billion, signaling 8.1% and 7.3% increases, respectively.
Zacks Rank & Key Picks
Ryan Specialty currently has a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Finance space are Assurant, Inc. (AIZ - Free Report) , CNO Financial Group, Inc. (CNO - Free Report) and Equitable Holdings, Inc. (EQH - Free Report) . While Assurant currently sports a Zacks Rank #1 (Strong Buy), CNO Financial and Equitable Holdings have a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Assurant’s current-year earnings is pegged at $22.28 per share, which indicates 12.7% year-over-year growth. It has witnessed five upward estimate revisions against none in the opposite direction in the past 60 days. AIZ beat earnings estimates in each of the last four quarters, with an average surprise of 17.7%.
The consensus mark for CNO Financial’s current-year earnings is pegged at $4.74 per share, which indicates 16.2% year-over-year growth. It has witnessed two upward estimate revisions against none in the opposite direction in the past 60 days. CNO beat earnings estimates in each of the last four quarters, with an average surprise of 23.2%.
The consensus estimate for Equitable Holdings’ current-year earnings is pegged at $7.18 per share, which signals a 15.6% year-over-year increase. It has witnessed four upward estimate revisions against none in the opposite direction in the past 60 days. EQH beat earnings estimates in three of the last four quarters and missed once.